• Facebook
  • Twitter
  • LinkedIn
  • Google +
  • RSS

Ferring Pharmaceuticals - Articles and news items

Ferring receives positive CHMP opinion for IVF aid Rekovelle

Industry news / 19 October 2016 / Niamh Louise Marriott, Digital Content Producer

Non-inferiority was demonstrated in a Phase 3 trial for the co-primary endpoints of ongoing pregnancy rate and ongoing implantation rate for Rekovelle…

Ferring announces data from its Phase III ESTHER trials

Industry news / 4 July 2016 / Victoria White, Digital Content Producer

ESTHER-1 assessed an individualised dosing regimen of follitropin delta compared to follitropin alfa in women undergoing their first cycle of IVF…

NICE says ‘yes’ to degarelix for men with prostate cancer and spinal metastases

Industry news / 1 July 2016 / Victoria White, Digital Content Producer

NICE has recommended Ferring’s Firmagon (degarelix) for men with advanced-hormone dependent prostate cancer and spinal metastases…

Trial of selepressin for treatment of septic shock begins

Industry news / 17 August 2015 / Victoria White

Ferring Pharmaceuticals has started patient enrollment in a Phase 2b/3 clinical trial of selepressin for the treatment of septic shock…